Results 141 to 150 of about 1,364 (160)
Some of the next articles are maybe not open access.

Droxidopa for Intravenous Vasopressor Weaning in the Intensive Care Unit: A Descriptive Study

Therapeutics
Background/Objectives: Our objective was to describe the safety and efficacy of enteral droxidopa, a norepinephrine prodrug, for intravenous (IV) vasopressor weaning in intensive care unit (ICU) patients.
Calvin Diep   +2 more
semanticscholar   +1 more source

Amantadine/droxidopa

Reactions weekly, 2023

semanticscholar   +1 more source

Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension.

Parkinsonism & Related Disorders, 2022
L. Marsili   +7 more
semanticscholar   +1 more source

Droxidopa management by an integrated health-system specialty pharmacy team.

Journal of the American Pharmacists Association, 2022
Sabrina Livezey   +6 more
semanticscholar   +1 more source

Rescue Therapy for an Old Challenging Problem: Droxidopa in the Management of Intradialytic Hypotension

Journal of the American Society of Nephrology, 2022
Lakshna Sankar, Kartik Kalra
semanticscholar   +1 more source

CLINICAL USE PATTERNS AND SAFETY PROFILE OF DROXIDOPA FOR INTRAVENOUS VASOPRESSOR WEANING IN SEPTIC SHOCK

Chest
Daniel Ying   +10 more
semanticscholar   +1 more source

Droxidopa

Reactions weekly

semanticscholar   +1 more source

Home - About - Disclaimer - Privacy